Lisa Foo Sells 10,000 Shares of Tenet Healthcare (NYSE:THC) Stock

Tenet Healthcare Corporation (NYSE:THC) EVP Lisa Foo sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $258.03, for a total transaction of $2,580,300.00. Following the sale, the executive vice president directly owned 32,053 shares of the company’s stock, valued at approximately $8,270,635.59. This trade represents a 23.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Tenet Healthcare Trading Up 0.9%

THC stock traded up $2.15 during midday trading on Friday, reaching $254.88. The company’s stock had a trading volume of 1,098,503 shares, compared to its average volume of 1,406,219. The business’s 50-day simple moving average is $192.10 and its 200-day simple moving average is $199.35. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. Tenet Healthcare Corporation has a 52 week low of $156.71 and a 52 week high of $262.68. The stock has a market cap of $21.96 billion, a PE ratio of 9.83, a price-to-earnings-growth ratio of 0.96 and a beta of 1.27.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The company had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. During the same quarter in the prior year, the business posted $4.02 EPS. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, sell-side analysts expect that Tenet Healthcare Corporation will post 21.09 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. PeakShares LLC increased its stake in Tenet Healthcare by 3.3% during the 1st quarter. PeakShares LLC now owns 1,693 shares of the company’s stock worth $319,000 after buying an additional 54 shares in the last quarter. Sanctuary Advisors LLC boosted its stake in shares of Tenet Healthcare by 0.5% in the first quarter. Sanctuary Advisors LLC now owns 11,900 shares of the company’s stock worth $2,246,000 after acquiring an additional 57 shares during the last quarter. Quadrant Capital Group LLC increased its position in shares of Tenet Healthcare by 0.7% during the fourth quarter. Quadrant Capital Group LLC now owns 8,134 shares of the company’s stock worth $1,616,000 after purchasing an additional 58 shares in the last quarter. Applied Finance Capital Management LLC raised its stake in Tenet Healthcare by 3.8% in the 1st quarter. Applied Finance Capital Management LLC now owns 1,644 shares of the company’s stock valued at $310,000 after purchasing an additional 60 shares during the last quarter. Finally, Syon Capital LLC boosted its stake in Tenet Healthcare by 5.3% during the 4th quarter. Syon Capital LLC now owns 1,254 shares of the company’s stock worth $249,000 after purchasing an additional 63 shares during the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

THC has been the subject of several analyst reports. Morgan Stanley boosted their target price on Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research report on Monday. TD Cowen lifted their price objective on shares of Tenet Healthcare from $233.00 to $263.00 and gave the stock a “buy” rating in a research note on Monday. UBS Group upped their target price on shares of Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a research note on Monday. Piper Sandler set a $308.00 price target on shares of Tenet Healthcare in a research report on Monday. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a $305.00 price target on shares of Tenet Healthcare in a report on Tuesday. Seventeen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $268.50.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.